Evidence map›Paper›PMID 27240326›Full record

ArticleMolecules (Basel, Switzerland)2016

Characterization of New PEEK/HA Composites with 3D HA Network Fabricated by Extrusion Freeforming.

Mohammad Vaezi, Cameron Black, David M R Gibbs, Richard O C Oreffo, Mark Brady, Mohamed Moshrefi-Torbati, Shoufeng Yang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Fabrication ofFrontiers in bioengineering and biotechnology · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Bioinspired Modifications of PEEK Implants for Bone Tissue Engineering.Frontiers in bioengineering and biotechnology · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mohammad VaeziEngineering Materials Group, Faculty of Engineering and the Environment, University of Southampton, Southampton SO17 1BJ, UK. mv1y11@soton.ac.uk.
Cameron BlackBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. crmb1e12@soton.ac.uk.
David M R GibbsBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. dmg1e12@soton.ac.uk.
Richard O C OreffoBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. richard.oreffo@soton.ac.uk.
Mark BradyInvibio Ltd., Thornton-Cleveleys, Lancashire FY5 4QD, UK. mbrady@invibio.com.
Mohamed Moshrefi-TorbatiEngineering Materials Group, Faculty of Engineering and the Environment, University of Southampton, Southampton SO17 1BJ, UK. m.m.torbati@soton.ac.uk.
Shoufeng YangEngineering Materials Group, Faculty of Engineering and the Environment, University of Southampton, Southampton SO17 1BJ, UK. s.yang@soton.ac.uk.
University of Southampton · GBHematology Oncology Associates · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Addition of bioactive materials such as calcium phosphates or Bioglass, and incorporation of porosity into polyetheretherketone (PEEK) has been identified as an effective approach to improve bone-implant interfaces and osseointegration of PEEK-based devices. In this paper, a novel production technique based on the extrusion freeforming method is proposed that yields a bioactive PEEK/hydroxyapatite (PEEK/HA) composite with a unique configuration in which the bioactive phase (i.e., HA) distribution is computer-controlled within a PEEK matrix. The 100% interconnectivity of the HA network in the biocomposite confers an advantage over alternative forms of other microstructural configurations. Moreover, the technique can be employed to produce porous PEEK structures with controlled pore size and distribution, facilitating greater cellular infiltration and biological integration of PEEK composites within patient tissue. The results of unconfined, uniaxial compressive tests on these new PEEK/HA biocomposites with 40% HA under both static and cyclic mode were promising, showing the composites possess yield and compressive strength within the range of human cortical bone suitable for load bearing applications. In addition, preliminary evidence supporting initial biological safety of the new technique developed is demonstrated in this paper. Sufficient cell attachment, sustained viability in contact with the sample over a seven-day period, evidence of cell bridging and matrix deposition all confirmed excellent biocompatibility.

Indexed as

BenzophenonesBiocompatible MaterialsBone DevelopmentBone SubstitutesDurapatiteHumansKetonesMaterials TestingOsseointegrationPolyethylene GlycolsPolymersPorosityPrinting, Three-DimensionalTissue EngineeringBenzophenonesBiocompatible MaterialsBone SubstitutesDurapatiteKetonespolyetheretherketonePolyethylene GlycolsPolymersadditive manufacturing (AM)bioactive PEEK/HA compositecompression moldingextrusion freeformingpolyetheretherketone (PEEK)porous PEEK

Identifiers

PMID27240326
PMCPMC6273399
OpenAlexW2402646161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.